Cognitive Stimulation Therapy (CST) for people with intellectual disabilities and dementia, a feasibility, randomised controlled trial

orth East London NHS Foundation Trust0 sites50 target enrollmentMarch 15, 2022

Overview

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37116994/ (added 02/05/2023)

Registry

who.int

Start Date

March 15, 2022

End Date

February 29, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

orth East London NHS Foundation Trust

•Current participant inclusion criteria as of 14/03/2023:
•1\. Premorbid mild or moderate intellectual disabilities (based on clinical notes)
•2\. Aged 18 and over
•3\. Clinical diagnosis of mild or moderate dementia based on service records
•4\. Ability to provide informed consent or (if the participant lacks capacity) availability of a personal consultee who has agreed to participate in the study
•5\. Ability to communicate in English
•Previous participant inclusion criteria:
•1\. Mild or moderate Learning disabilities
•2\. ICD\-10 diagnosis of mild or moderate dementia

•Current participant exclusion criteria as of 14/03/2023:
•1\. Significant visual or hearing impairment that may interfere with participation
•2\. Significant physical illness or disability, affecting the ability to attend groups
•3\. Significant behavioural problems that could affect participation (e.g. aggressive behaviour)
•Previous participant exclusion criteria:
•1\. Severe learning disabilities
•2\. Severe dementia
•3\. Visual or hearing impairment that prevents participation